HbA1c isn’t just a number to glance at, compare to standard levels, and decide if someone is diabetic. While that’s often what we do when reviewing a blood sugar profile, the story behind this ...

This study from Kerman University of Medical Sciences have that empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1 ...

By week 12, HbA1c significantly improved among participants on twice-daily berberine ursodeoxycholate at 500 mg (-0.4%, 95% ...

If you continue to have this issue please contact [email protected]. Orforglipron conferred HbA1c reductions of 1.3 to 1.6 percentage points at 40 weeks in adults with type 2 diabetes.

Metformin and SGLT2 inhibitors are associated with similar rates of incident gout among patients with type 2 diabetes.

Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

This indicator covers the proportion of children and young people aged under 18 years with type 1 diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It ...